These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 21557216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS.
    J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S, Cho NY, Choi M, Yoo EJ, Kim JH, Kang GH.
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [Abstract] [Full Text] [Related]

  • 7. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.
    Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.
    Gastroenterology; 2013 Aug; 145(2):348-56.e1-2. PubMed ID: 23665275
    [Abstract] [Full Text] [Related]

  • 8. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
    Zlobec I, Bihl MP, Foerster A, Rufle A, Lugli A.
    Histopathology; 2012 Nov; 61(5):777-87. PubMed ID: 22803799
    [Abstract] [Full Text] [Related]

  • 9. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA.
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [Abstract] [Full Text] [Related]

  • 10. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
    Sanchez JA, Krumroy L, Plummer S, Aung P, Merkulova A, Skacel M, DeJulius KL, Manilich E, Church JM, Casey G, Kalady MF.
    Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
    [Abstract] [Full Text] [Related]

  • 11. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
    Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.
    Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
    [Abstract] [Full Text] [Related]

  • 12. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.
    Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
    [Abstract] [Full Text] [Related]

  • 13. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH, Rhee YY, Kim KJ, Cho NY, Lee HS, Kang GH.
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [Abstract] [Full Text] [Related]

  • 14. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
    Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, Campan M, Laird PW, Loda M, Fuchs CS.
    Gut; 2006 Jul; 55(7):1000-6. PubMed ID: 16407376
    [Abstract] [Full Text] [Related]

  • 15. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA.
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [Abstract] [Full Text] [Related]

  • 16. Association between molecular subtypes of colorectal cancer and patient survival.
    Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, Newcomb PA.
    Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443
    [Abstract] [Full Text] [Related]

  • 17. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
    Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.
    Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
    [Abstract] [Full Text] [Related]

  • 18. Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta-analysis.
    Lin L, Chen GY, Xu CW, Wang HY, Wu YF, Fang MY.
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C191-C198. PubMed ID: 28230016
    [Abstract] [Full Text] [Related]

  • 19. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.
    BMC Cancer; 2008 Sep 09; 8():255. PubMed ID: 18782444
    [Abstract] [Full Text] [Related]

  • 20. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.
    Ferracin M, Gafà R, Miotto E, Veronese A, Pultrone C, Sabbioni S, Lanza G, Negrini M.
    J Pathol; 2008 Apr 09; 214(5):594-602. PubMed ID: 18241079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.